Owkin
Full-time · Paris, France
Job description
Your main mission will be:
to contribute to position Owkin’s Data Platform product in the competitive landscape in terms of offering (data access modalities / datasets) and in terms of pricing
to support our dataset catalog solution & continuous improvements
to improve Data Platform business scalability
to support the BD team on the data assessments needed for industrial projects
WHERE YOUR EXPERTISE IS NEEDED
Collaborate closely with the BD team to help them better deliver business project
Analyse KPIs and objectives to propose action plan and actionable recommendations
Update and develop our CRM tool
Realize market studies on specific diseases and/or geographic areas
Support the BD team by presenting our capabilities to clients
Interact with the Partnerships managers to assess datasets and conditions of access
Propose tools and solutions to professionalise data assessments ( “search engine”, data analysis, bibliometric networks, external resources)
Lead data catalogue development and continuous improvements, in order to answer BD, partnerships and executive teams.
Benefits:
Competitive salary and benefits package;
Opportunity to work with an international team with high technical and scientific backgrounds;
Friendly and informal working environment;
Flexible work organization and access to remote work;
Beautiful and well positioned offices in Paris (Petites Ecuries), London (Holborn), Nantes (historic Center), Basel, Boston (Cambridge) and NYC (Union Square) with numerous and various team activities and events.
This job is not in any teams
This job is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.